Belimumab use during pregnancy: Interim results of the belimumab pregnancy registry

por Juliao, Patricia, Wurst, Keele, Pimenta, Jeanne M., Gemzoe, Kim, Landy, Helain, Moody, M. Anthony, Tilson, Hugh, Covington, Deborah, Moore, Tammy, Marino, Rebecca, Gilbride, Jennifer, Liu, Andrew, Meizlik, Paige, Petri, Michelle
Publicado 2022

Phase III/IV, Randomized, Fifty‐Two–Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus

por Ginzler, Ellen, Guedes Barbosa, Luiz Sergio, D'Cruz, David, Furie, Richard, Maksimowicz‐McKinnon, Kathleen, Oates, James, Santiago, Mittermayer Barreto, Saxena, Amit, Sheikh, Saira, Bass, Damon L., Burriss, Susan W., Gilbride, Jennifer A., Groark, James G., Miller, Michelle, Pierce, Amy, Roth, David A., Ji, Beulah
Publicado 2021

Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus

por Urowitz, Murray B., Aranow, Cynthia, Asukai, Yumi, Bass, Damon L., Bruce, Ian N., Chauhan, Deven, Dall'Era, Maria, Furie, Richard, Fox, Norma Lynn, Gilbride, Jennifer A., Hammer, Anne, Ginzler, Ellen M., Gonzalez‐Rivera, Tania, Levy, Roger A., Merrill, Joan T., Quasny, Holly, Roth, David A., Stohl, William, van Vollenhoven, Ronald, Wallace, Daniel J., Petri, Michelle
Publicado 2022